Filter
1702
Filtered Results: 1702
Text search:
European
Medicines
Agency
Featured
Recommendations
157
New Publications
353
Language
Document type
No document type
801
Studies & Reports
402
Guidelines
247
Manuals
105
Strategic & Response Plan
56
Fact sheets
38
Training Material
22
Situation Updates
20
Resource Platforms
5
Brochures
3
App
1
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
94
Global
87
Ukraine
55
Eastern Europe
35
Africa
30
Kenya
28
Ethiopia
25
Sierra Leone
22
Nigeria
21
Ghana
21
Zambia
21
Liberia
20
Germany
19
Myanmar / Burma
19
India
18
Nepal
18
Syria
18
Latin America and the Carribbean
17
Eastern Europe and Central Asia
17
Russia
16
South Africa
15
Guinea
12
Uganda
12
South–East Asia Region
12
Philippines
11
Bangladesh
11
West and Central Africa
11
Venezuela
11
Rwanda
10
Moldova
10
Zimbabwe
9
Malawi
9
East and Southern Africa
9
Senegal
8
Congo, Democratic Republic of
8
Tanzania
8
Namibia
8
Tajikistan
8
Thailand
7
Indonesia
7
Georgia
7
Burkina Faso
6
South Sudan
6
Jordan
6
Brazil
6
North Macedonia
6
Colombia
6
Middle East and North Africa
6
Cameroon
5
Cambodia
5
Mozambique
5
Eswatini/ Swaziland
5
Yemen
5
Paraguay
5
Asia
5
Albania
5
Haiti
4
Somalia
4
Sudan
4
Benin
4
Hungary
4
Botswana
4
Poland
4
USA
3
Pakistan
3
Afghanistan
3
Lebanon
3
Turkey
3
China
3
Serbia
3
Lesotho
3
Laos
3
Romania
3
Kyrgyzstan
3
Kazakhstan
3
Vietnam
3
Jamaica
3
Belarus
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Iraq
2
Egypt
2
Central African Republic
2
Argentina
2
Bolivia
2
Libya
2
Madagascar
2
Sri Lanka
2
Chile
2
Western Pacific Region
2
Bulgaria
2
Estonia
2
Iran
2
Uzbekistan
2
Bosnia and Herzegovina
2
Mali
1
Saudi Arabia
1
Niger
1
Mauritania
1
Papua New Guinea
1
Peru
1
Ecuador
1
El Salvador
1
Greece
1
Mexico
1
Bhutan
1
Armenia
1
Mongolia
1
Southern Africa
1
Slovakia
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
158
Public Health
97
Women & Child Health
77
Key Resources
72
Pharmacy & Technologies
30
Capacity Building
14
Toolboxes
COVID-19
165
Mental Health
164
HIV
137
TB
125
AMR
110
Planetary Health
82
Conflict
74
Rapid Response
71
Pharmacy
59
Refugee
52
Disability
49
Ebola
47
Global Health Education
42
NCDs
33
Caregiver
31
Health Financing Toolbox
27
NTDs
23
Specific Hazards
18
Natural Hazards
14
Zika
14
Polio
6
Cholera
3
Social Ethics
1
A United Nations System Commitment for
Action to assist Member States delivering on
the post-2020 global biodiversity framework
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action ...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
Operation update 01/04/2022
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fatal, but in many cases, TB is preventable and treatable. This report examines the human rights impact of...
In 2015, 26% of the deaths of 5.9 million children who died before reaching their fifth birthday could have been prevented
through addressing environmental risks – a shocking missed opportunity. The prenatal and early childhood period represents
a window of particular vulnerability, where enviro...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
Medical care for people caught up in armed conflict and other insecure environments saves lives and alleviates suffering. It is one of the most immediate and high priority needs of an affected population and is often the first type of response activated and/or requested by authorities and affected c...
